Attenuated Salmonella Typhimurium expressing Salmonella Paratyphoid A O-antigen induces protective immune responses against two Salmonella strains

References

• Bhan MK, R B, Bhatnagar S. Typhoid and paratyphoid fever. Lancet. 2005;366(9487):749–762.
   PubMed Web of Science ®Google Scholar
• Buckle GC, Walker CL, Black RE. Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010. J Glob Health. 2012 Jun;2(1):010401. PubMed PMID: 23198130; PubMed Central PMCID: PMC3484760.
   PubMedGoogle Scholar
• Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ. 2004;82(5):346–353.
   PubMed Web of Science ®Google Scholar
• Crump JA, Mintz ED. Global trends in typhoid and paratyphoid Fever. Clin Infect Dis. 2010 Jan 15;50(2):241–246. PubMed PMID: 20014951; PubMed Central PMCID: PMCPMC2798017.
   PubMed Web of Science ®Google Scholar
• Arndt MB, Mosites EM, Tian M, et al. Estimating the burden of paratyphoid a in Asia and Africa. PLoS Negl Trop Dis. 2014 Jun;8(6):e2925. PubMed PMID: 24901439; PubMed Central PMCID: PMCPMC4046978.
   PubMed Web of Science ®Google Scholar
• Martin LB, Simon R, MacLennan CA, et al. Status of paratyphoid fever vaccine research and development. Vaccine. 2016 Jun 03;34(26):2900–2902. PubMed PMID: 27083427.
   PubMed Web of Science ®Google Scholar
• Sahastrabuddhe S, Carbis R, Wierzba TF, et al. Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development. Expert Rev Vaccines. 2013 Sep;12(9):1021–1031. PubMed PMID: 24053396.
   PubMed Web of Science ®Google Scholar
• Konadu EY, Lin F-YC, Hó VA, et al. Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2-to 4-year-old children in Vietnam. Infect Immun. 2000;68(3):1529–1534.
   PubMed Web of Science ®Google Scholar
• Micoli F, Rondini S, Gavini M, et al. O: 2-CRM 197 conjugates against Salmonella paratyphi A. PloS One. 2012;7(11):e47039.
   PubMed Web of Science ®Google Scholar
• Kothari S, Kim JA, Carbis R. OL-072 Process development of an affordable bivalent conjugate vaccine against the two major causes of enteric fever, Salmonella typhi and Salmonella paratyphi A. Inter J Infect Dis. 2011;15(4):S40.
   Google Scholar
• Kothari S, Kim J-A, Kothari N, et al. Purification of O-specific polysaccharide from lipopolysaccharide produced by Salmonella enterica serovar Paratyphi A. Vaccine. 2014;32(21):2457–2462.
   PubMed Web of Science ®Google Scholar
• Roland KL, Tinge SA, Kochi SK, et al. Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidates. Vaccine. 2010 May 07;28(21):3679–3687. PubMed PMID: 20338215.
   PubMed Web of Science ®Google Scholar
• Tennant SM, Levine MM. Live attenuated vaccines for invasive Salmonella infections. Vaccine. 2015 Jun 19;33(Suppl. 3):C36–41. PubMed PMID: 25902362; PubMed Central PMCID: PMC4469493.
   PubMed Web of Science ®Google Scholar
• Gat O, Galen JE, Tennant S, et al. Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines. PLoS Negl Trop Dis. 2011 Nov;5(11):e1373. PubMed PMID: 22069504; PubMed Central PMCID: PMCPMC3206010.
   PubMed Web of Science ®Google Scholar
• Luk J, Lindberg A. Anti-Salmonella lipopolysaccharide monoclonal antibodies: characterization of Salmonella BO-, CO-, DO-, and EO-specific clones and their diagnostic usefulness. J Clin Microbiol. 1991;29(11):2424–2433.
   PubMed Web of Science ®Google Scholar
• Slauch JM, Mahan MJ, Michetti P, et al. Acetylation (O-factor 5) affects the structural and immunological properties of Salmonella Typhimurium lipopolysaccharide O antigen. Infect Immun. 1995;63(2):437–441.
   PubMed Web of Science ®Google Scholar
• Konadu E, Shiloach J, Bryla DA, et al. Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls. Infect Immun. 1996;64(7):2709–2715.
   PubMed Web of Science ®Google Scholar
• Szu SC, Li X, Stone AL, et al. Relation between structure and immunologic properties of the Vi capsular polysaccharide. Infect Immun. 1991;59(12):4555–4561.
   PubMed Web of Science ®Google Scholar
• Hong Y, Duda KA, Cunneen MM, et al. The WbaK acetyltransferase of Salmonella enterica group E gives insights into O antigen evolution. Microbiology. 2013 Nov;159(Pt 11):2316–2322. PubMed PMID: 24014662.
   PubMedGoogle Scholar
• Liu B, Knirel YA, Feng L, et al. Structural diversity in Salmonella O antigens and its genetic basis. FEMS Microbiol Rev. 2014 Jan;38(1):56–89. PubMed PMID: 23848592.
   PubMed Web of Science ®Google Scholar
• Samuel G, Reeves P. Biosynthesis of O-antigens: genes and pathways involved in nucleotide sugar precursor synthesis and O-antigen assembly. Carbohydr Res. 2003;338(23):2503–2519.
   PubMed Web of Science ®Google Scholar
• Hong Y. Genetic basis for O-antigen diversity in Escherichia coli and Salmonella enterica. Mol Microbiol. 2014;84:620–630.
   Google Scholar
• Liu MA, Stent TL, Hong Y, et al. Inefficient translocation of a truncated O unit by a Salmonella Wzx affects both O-antigen production and cell growth. FEMS Microbiol Lett. 2015 ;362(9):S73–S85.
   Web of Science ®Google Scholar
• Hong Y, Cunneen MM, Reeves PR. The Wzx translocases for Salmonella enterica O-antigen processing have unexpected serotype specifity. Mol Microbiol. 2012;84(4):620–630.
   PubMed Web of Science ®Google Scholar
• Hong Y, Reeves PR. Diversity of O-antigen repeat unit structures can account for the substantial sequence variation of wzx translocases. J Bacteriol. 2014 May;196(9):1713–1722. PubMed PMID: 24532778; PubMed Central PMCID: PMC3993327.
   PubMed Web of Science ®Google Scholar
• Hong Y, Morcilla VA, Liu MA, et al. Three Wzy polymerases are specific for particular forms of an internal linkage in otherwise identical O units. Microbiology. 2015;161(8):1639–1647.
   PubMedGoogle Scholar
• Xin W, Wanda SY, Li Y, et al. Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis. Infect Immun. 2008 Jul;76(7):3241–3254. PubMed PMID: 18458067; PubMed Central PMCID: PMC2446722.
   PubMed Web of Science ®Google Scholar
• Curtiss R, Kelly SM. Salmonella Typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect Immun. 1987 Dec 1;55(12):3035–3043.
   PubMed Web of Science ®Google Scholar
• Curtiss R 3rd, Goldschmidt RM, Fletchall NB, et al. Avirulent Salmonella Typhimurium delta cya delta crp oral vaccine strains expressing a streptococcal colonization and virulence antigen. Vaccine. 1988 Apr;6(2):155–160. PubMed PMID: 3291452; eng.
   PubMed Web of Science ®Google Scholar
• Liu X, Liu Q, Xiao K, et al. Attenuated Salmonella Typhimurium delivery of a novel DNA vaccine induces immune responses and provides protection against duck enteritis virus. Vet Microbiol. 2016 Apr 15;186:189-98.
   Web of Science ®Google Scholar
• Xin W, Wanda SY, Zhang X, et al. The Asd(+)-DadB(+) dual-plasmid system offers a novel means to deliver multiple protective antigens by a recombinant attenuated Salmonella vaccine. Infect Immun. 2012 Oct;80(10):3621–3633. PubMed PMID: 22868499; PubMed Central PMCID: PMC3457550.
   PubMed Web of Science ®Google Scholar
• Nakayama K, Kelly SM, Curtiss R. Construction of an Asd+ expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Nat Biotechnol. 1988;6(6):693–697.
   Google Scholar
• Trent MS, Pabich W, Raetz CR, et al. A PhoP/PhoQ-induced Lipase (PagL) that catalyzes 3-O-deacylation of lipid A precursors in membranes of Salmonella Typhimurium. J Biol Chem. 2001 Mar 23;276(12):9083–9092. PubMed PMID: 11108722.
   PubMed Web of Science ®Google Scholar
• Kawasaki K, Ernst RK, Miller SI. 3-O-deacylation of lipid A by PagL, a PhoP/PhoQ-regulated deacylase of Salmonella Typhimurium, modulates signaling through Toll-like receptor 4. J Biol Chem. 2004 May 07;279(19):20044–20048. PubMed PMID: 15014080.
   PubMed Web of Science ®Google Scholar
• Kong Q, Six DA, Roland KL, et al. Salmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity. J Iimmunol. 2011 Jul 1;187(1):412–423. PubMed PMID: 21632711; PubMed Central PMCID: PMC3119770.
   PubMed Web of Science ®Google Scholar
• Curtiss R 3rd, Xin W, Li Y, et al. New technologies in using recombinant attenuated Salmonella vaccine vectors. Crit Rev Immunol. 2010;30(3):255.
   PubMed Web of Science ®Google Scholar
• Simon R, Levine MM. Glycoconjugate vaccine strategies for protection against invasive Salmonella infections. Hum Vaccin Immunother. 2012 Apr;8(4):494–498. PubMed PMID: 22370510; PubMed Central PMCID: PMC3426074.
   PubMed Web of Science ®Google Scholar
• Li P, Liu Q, Luo H, et al. O-serotype conversion in Salmonella Typhimurium induces protective immune responses against invasive non-typhoidal Salmonella infections. Front Immunol. 2017;8. DOI:10.3389/fimmu.2017.01647
   Web of Science ®Google Scholar
• Li P, Liu Q, Luo H, et al. Bi-valent polysaccharides of Vi capsular and O9 O-antigen in attenuated Salmonella Typhimurium induce strong immune responses against these two antigens. npj Vaccines. 2018;3(1). DOI:10.1038/s41541-017-0041-5
   Google Scholar
• Kong Q, Yang J, Liu Q, et al. Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar Typhimurium. Infect Immun. 2011 Oct;79(10):4227–4239. PubMed PMID: 21768282; PubMed Central PMCID: PMC3187260.
   PubMed Web of Science ®Google Scholar
• Han Y, Liu Q, Willias S, et al. A bivalent vaccine derived from attenuated Salmonella expressing O-antigen polysaccharide provides protection against avian pathogenic Escherichia coli O1 and O2 infection. Vaccine. 2018 Feb 14;36(8):1038–1046. PubMed PMID: 29358057.
   PubMed Web of Science ®Google Scholar
• Parker DC. T cell-dependent B cell activation. Annu Rev Immunol. 1993;11:331–360. PubMed PMID: 8476565.
   PubMed Web of Science ®Google Scholar
• Angelakopoulos H, Hohmann EL. Pilot study of phoP/phoQ-deleted Salmonella enterica Serovar Typhimurium expressing helicobacter pylori urease in adult volunteers. Infect Immun. 2000;68(4):2135–2141.
   PubMed Web of Science ®Google Scholar
• Hindle Z, Chatfield SN, Phillimore J, et al. Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers. Infect Immun. 2002;70(7):3457–3467.
   PubMed Web of Science ®Google Scholar
• Hohmann EL, Oletta CA, Killeen KP, et al. phoP/phoQ-deleted Salmonella typhi (TY800) is a safe and immunogenic single dose typhoid fever vaccine in volunteers. J Infect Dis. 1996;173(6):1408–1414.
   PubMed Web of Science ®Google Scholar
• DiPetrillo MD, Tibbetts T, Kleanthous H, et al. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers. Vaccine. 1999;18(5):449–459.
   PubMed Web of Science ®Google Scholar
• Tacket CO, Sztein MB, Wasserman SS, et al. Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in US volunteers. Infect Immun. 2000;68(3):1196–1201.
   PubMed Web of Science ®Google Scholar
• Liu Q, Liu Q, Zhao X, et al. Immunogenicity and cross-protective efficacy induced by outer membrane proteins from salmonella Typhimurium mutants with truncated LPS in mice. Int J Mol Sci. 2016;17(3):416.
   PubMed Web of Science ®Google Scholar
• Edwards RA, Keller LH, Schifferli DM. Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Gene. 1998;207(2):149–157.
   PubMed Web of Science ®Google Scholar
• Guzman L-M, Belin D, Carson MJ, et al. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol. 1995;177(14):4121–4130.
   PubMed Web of Science ®Google Scholar
• Galán JE, Nakayama K, Curtiss R. Cloning and characterization of the asd gene of Salmonella Typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene. 1990;94(1):29–35.
   PubMed Web of Science ®Google Scholar
• Dower WJ, Miller JF, Ragsdale CW. High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res. 1988;16(13):6127–6145.
   PubMed Web of Science ®Google Scholar
• Sambrook J, Russell DW. Molecular cloning: a laboratory manual. 3rd ed. UK: Coldspring-Harbour Laboratory Press; 2001.
   Google Scholar
• Roland K, Curtiss R III, Sizemore D. Construction and evaluation of a Δcya Δcrp Salmonella Typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens. Avian Dis. 1999;43:429–441.
   PubMed Web of Science ®Google Scholar
• Gibson DG, Young L, Chuang R-Y, et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods. 2009;6(5):343–345.
   PubMed Web of Science ®Google Scholar
• Wang S, Li Y, Shi H, et al. Immune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine. Infect Immun. 2010 Jul;78(7):3258–3271. PubMed PMID: 20479086; PubMed Central PMCID: PMCPMC2897375.
   PubMed Web of Science ®Google Scholar
• Curtiss R 3rd, Nakayama K, Kelly SM. Recombinant avirulent Salmonella vaccine strains with stable maintenance and high level expression of cloned genes in vivo. Immunol Invest. 1989 Jan-May;18(1–4):583–596. PubMed PMID: 2659521; eng.
   PubMed Web of Science ®Google Scholar
• Kong W, Sy W, Zhang X, et al. Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment. Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9361–9366. PubMed PMID: 18607005; PubMed Central PMCID: PMC2453710
   PubMed Web of Science ®Google Scholar
• Hitchcock PJ, Brown TM. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol. 1983;154(1):269–277.
   PubMed Web of Science ®Google Scholar
• Kong Q, Liu Q, Roland KL, et al. Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar Typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen. Infect Immun. 2009 Dec;77(12):5572–5582. PubMed PMID: 19805538; PubMed Central PMCID: PMC2786485.
   PubMed Web of Science ®Google Scholar
• Huang C, Liu Q, Luo Y, et al. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge. Vaccine. 2016 Aug 5;34(36):4285–4292. PubMed PMID: 27423383; PubMed Central PMCID: PMCPMC5206759.
   PubMed Web of Science ®Google Scholar
• Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol. 1938;27(3):493–497.
   Google Scholar
• McKay GA, Woods DE, MacDonald KL, et al. Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance. Infect Immun. 2003;71(6):3068–3075.
   PubMed Web of Science ®Google Scholar